Skip to main content

Alector Inc. Common Stock (ALEC)

About The Company

ALEC Stock Market Logo

Alector Inc is a clinical stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies which are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline product inlcude AL001, AL002, AL003, and AL101.

IPO Year Sector Industry
2019 Health Care Biotechnology: Pharmaceutical Preparations

Alector Inc. (ALEC) Latest News

Company Contact & Address (ALEC)

Corporate Headquarters Phone Website
131 OYSTER POINT BOULEVARD SUITE 600,
SOUTH SAN FRANCISCO,
California,
94080,
United States
+1 415 231-5660 Official ALEC Website

ALEC Key Executives

Ownership and management information.

Key Data Points*

Exchange Not Available Market Cap Not Available
Sector Health Care P/E Ratio Not Available
Industry Biotechnology: Pharmaceutical Preparations Forward P/E 1 Yr. Not Available
1 Year Target Not Available Earnings Per Share (EPS) Not Available
Today’s High/Low Not Available Annualized Dividend Not Available
Share Volume Not Available Ex Dividend Date Not Available
Average Volume Not Available Dividend Pay Date Not Available
Previous Close Not Available Current Yield Not Available
52 Week High/Low Not Available Beta Not Available

* Information and data may delayed

Officers & Directors @ ALEC

Jobs & Employment at Alector Inc.

LinkedIn Company Page https://www.linkedin.com/company/alector
Official Career & Employment Page Careers & Jobs at Alector Inc. (ALEC)

Related & Similar Stock Symbols

ULCC Stock Market Price & News

ULCC

Frontier Group Holdings Inc. Common Stock

LGO Stock Market Price & News

LGO

Largo Inc. Common Shares

LBTYA Stock Market Price & News

LBTYA

Liberty Global plc Class A Ordinary Shares